GOOD NEWS ON HEPATITIS
Lamivudine, or 3TC, is best known for its success as part of the AIDS "cocktail." But a study out last week shows that the drug may be useful in treating chronic hepatitis B, a liver disease with more than 300 million sufferers worldwide. In a one-year trial on Chinese patients, viral levels in the blood fell more than 90% for those who took the drug.
BAD NEWS ON BREAST CANCER
Tamoxifen, used to treat breast cancer, made headlines in April when a study suggested it could also prevent the disease. But this week, two European studies showed...